Overview

A Study Measuring the Effectiveness of BMS-986256 Combined With Oral Contraceptive in Healthy Female Participants

Status:
Active, not recruiting

Trial end date:
2021-02-01

Target enrollment:

Participant gender:

Summary

A comparative study of BMS-986256 with a combined oral contraceptive in healthy female participants to determine the effectiveness when taken together

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Contraceptive Agents
Contraceptives, Oral
Estradiol
Ethinyl Estradiol
Norethindrone
Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination
Norinyl